iScience. 2025 Aug 16;28(9):113378. doi: 10.1016/j.isci.2025.113378. eCollection 2025 Sep 19.
ABSTRACT
La Crosse virus (LACV) is a leading cause of pediatric encephalitis in the US, with no approved vaccines or antivirals. Weanling mice (3 weeks old) are highly susceptible to lethal LACV infection, whereas adult mice (≥8 weeks old) are resistant. Here, we show that adult mice generate robust, polyfunctional CD4+ and CD8+ T cell responses targeting LACV structural and non-structural proteins, with high production of IFN-γ, granzyme B, IL-2, and TNF-α. These T cells display strong in vivo cytotoxicity against cells pulsed with Gc and N antigens. In contrast, weanlings mount weak T cell responses and exhibit 100% mortality by 7 days post-infection. Immunization of weanling mice with LFn-LACV-Gc or -N enhanced cytotoxic T cell activity, reduced brain viral loads, and significantly improved survival, highlighting their potential as vaccine candidates. Our study identifies age-dependent T cell responses as key correlates of protection and supports vaccine development against LACV-induced pediatric encephalitis.
PMID:40970210 | PMC:PMC12441678 | DOI:10.1016/j.isci.2025.113378
